TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Number of participants that complete all visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Patient-reported program evaluation questionnaire scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Annualized hospitalization rates
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Incidence of brain radionecrosis
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of patients who complete the study
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Cancer-specific quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of Adverse Events from Day 1 to 28
Endpoint domain: Adverse events/effects
Primary endpoint: Serious game performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in the Kansas City Cardiomyopathy Questionnaire (KCCQ) Clinical Summary Score (CSS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Occurrence of the Composite Endpoint of Cardiovascular (CV) Death and/or Heart Failure (HF) Events Over Time
Endpoint domain: Mortality/survival
Primary endpoint: Cognitive status assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Catheter-related complication rate
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of Dying and Death (QODD)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: 24hr total stool output volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Plasma proteomic biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Model or classifier performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall response rate (ORR) by IRC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of fat mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Stage of the disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall response rate (ORR) by Response Criteria in Solid Tumors (RECIST) v1.1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: intra-urethral pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Clinical Global Impression-Severity focused on Agitation/Aggression (CGI-S A/A)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Borderline Personality Disorder Checklist (BPDCL)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Laboratory markers of immunity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: probing pocket depth (PD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: In-Home therapist time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in hs-CTRP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: structural changes in atherosclerosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: physiological changes in atherosclerosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: biochemical profile in atherosclerosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: WOMAC pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arterial blood gasses (ABG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neutrophil to lymphocyte ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of grade 3 and above adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: healing of ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Proportion of patients with Suture length/Wound length (SL/WL) ratio ≥ 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Aggregate Adverse Symptom Score
Endpoint domain: Adverse events/effects
Primary endpoint: Change of the State-Trait Anxiety Inventory scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change of the Overall Comfort Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from Baseline in Pyruvate Kinase Deficiency Diary (PKDD) Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline in Pyruvate Kinase Deficiency Impact Assessment (PKDIA) Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from Baseline in Work Productivity and Activity Impairment Questionnaire: Specific Health Problem (WPAI: SHP) 2.0 Score
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change from Baseline in Functional Assessment of Cancer Therapy-Anemia (FACT-An)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Total practice time in minutes
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Participants' symptom management by emotional disposition
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Feasibility of study application measured by participant ability
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of patients with CD34+ cells ≥2×106/kg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Incidence rate of postoperative intra-abdominal infection
Endpoint domain: Adverse events/effects
Primary endpoint: occurrence of postoperative opioid-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Regression of cervix cytological abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Quality of life of women with urinary incontinence
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: sleep wake patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: chronotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6 month survival
Endpoint domain: Mortality/survival
Primary endpoint: Trunk rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cobb angles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major ischaemic events
Endpoint domain: Mortality/survival
Primary endpoint: Bleeding type 2 or higher
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of initial clinical cure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reliability of the Attention Assessment Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Validity of the Attention Assessment Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mavacamten effect on NT-proBNP levels (at rest)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mavacamten effect on cTnT levels (at rest)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Adverse Childhood Experiences
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Conflict Tactic Scale
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Duration of Clostridium difficile diarrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: 360° Turn Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alternative Step Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pen Pickup Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in 10-meter over ground walking-speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in EMG Pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to complete healing (graft >99% re-epithelialized)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healing of the nipple (VAS=Visual Analog Scale) overall healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ICG-r score at 6 months post-death
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: ICG-r score at 12 months post-death
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in ICG-r score from 6 months to 12 months post-death
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Speech intelligibility (% words repeated back correctly)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Implementation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Adverse Events Rates
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in respiratory tract metabolite profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: BIDFS at one year
Endpoint domain: Mortality/survival
Primary endpoint: Childhood apraxia of speech assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of circulating biomarkers correlating with beta cell death
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Responsiveness of the newly developed bowel e-diary
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Parenting self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Socially Supportive Activity Inventory
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Cognition measured by Symbol Digit Modality Test (SDMT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Neurogenic lower urinary tract dysfunction symptoms measured by Neurogenic Bladder Symptom Score (NBSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Relative Peak Propulsive Power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: modified Relative Strength Index (mRSI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Landing Force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Qualitative changes in masses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation of masses with chemotherapy response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Functional Near-infrared Spectroscopy from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Synchronous Finger Motor Control Timing Abilities from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Continuous Finger Motor Control Timing Abilities from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Unified Parkinson Disease Rating Scale (UPDRS) from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Outcome of billing for the HealthBeacon Injection Care Management System (ICMS)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Occurrence of hemorrhagic events
Endpoint domain: Adverse events/effects
Primary endpoint: Patient satisfaction (CSQ-8 scores)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: FEV1 (%) difference between portable and standard spirometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: PEF (L/sec) difference between portable and standard spirometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Vaccine Intentions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Craniovertebral angle (CV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cervical Spine range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cervical Propioception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone gain height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reliability of the SEM Scanner
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Validity of the SEM Scanner
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of PVX7 as assessed by adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in ctDNA level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of matched mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body Circumferences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numeric post-operative pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects achieving PASI 75 response at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Proportion of subjects achieving sPGA 0/1 response at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: stroke volume (SV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pelvic Floor Muscle Strength Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activities-specific Balance Confidence (ABC) scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Frequency of dry eye symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of dry eye symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total Incidence of Dose Limiting Toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Total Incidence of Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Total Incidence of Serious Adverse Events (SAEs) Leading to Discontinuation or Death
Endpoint domain: Adverse events/effects
Primary endpoint: Patient Dignity Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Difference in polysomnography results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immunological responses of B cell subsets
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Diagnostic yield of sample(s)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants achieving ultra-lung protective ventilation (ULPV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse Events related to study device
Endpoint domain: Adverse events/effects
Primary endpoint: Adverse Events related to study procedure
Endpoint domain: Adverse events/effects
Primary endpoint: Adverse Device Effect (ADE)
Endpoint domain: Adverse events/effects
Primary endpoint: Adverse Events leading to study withdrawal
Endpoint domain: Adverse events/effects
Primary endpoint: Adverse events of special interest (AESIs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of atrial fibrillation recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diabetes management self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Quantification of Cell Death and Immune Cell Biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sensitivity and specificity of thoracic ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in self-reported depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in self-reported stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Scores from Quality of Life Questionnaire-Core 30 Rating (QLQ-C30)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percentage of subjects with ≥2 grade chronic radiation rectal injury
Endpoint domain: Adverse events/effects
Primary endpoint: Pressure wire measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Subject-reported Ocular Dryness Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Schirmer Test Change From Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Western Ontario Osteoarthritis of the Shoulder (WOOS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Markers of inflammation, fibrosis or sphingolipid accumulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression to Respiratory Failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Diagnosis of SPAD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Assessment of anti-PnPS IgG response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Bedside mobility assessment tool (BMAT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete mucosal healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Patient-based recovery curves
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: brain metabolic pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: HRCT scan variables
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Racism-related stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in patient reported visual function
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: NRS scores of patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alveolar bone density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alveolar bone volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiologists' satisfaction of the quality of images
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical response to immune checkpoint inhibitors (ICIs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in 6-minute walking test (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: extubation quality scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical attachment level (CAL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oral health outcomes
Primary endpoint: Periodontal Pocket Depth (PPD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oral health outcomes
Primary endpoint: Muscle Strength Improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Still birth/fetal demise
Endpoint domain: Mortality/survival
Primary endpoint: Peripheral vascular blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Expression of CXCL5 in urothelial carcinoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of Postoperative Delirium (POD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: survival one month after positive SARS Cov 2 RT-PCR test
Endpoint domain: Mortality/survival
Primary endpoint: Area under the concentration-time curve from time zero to time of last quantifiable concentration (AUC 0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve from time zero to infinity (AUC 0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleep health composite
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Chronotype
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Confidence in performing the self-test
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of time spent within glycemic target range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline well-being at week 12
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Optical microscope reading accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Automatic pre-classification performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shoulder kinematics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of Participants Completing 2-week Study Visit
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention